Matches in Nanopublications for { ?s ?p "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42983.RA-e-NZLCUmXmso2LWZWzDMsoJcq05pyE1Ife1QODxQSw130_provenance.
- NP295318.RAugZSaZcys6wYHWzvIgMlN7WYbujXX-IQQUsIcBcMx84130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295318.RAugZSaZcys6wYHWzvIgMlN7WYbujXX-IQQUsIcBcMx84130_provenance.
- NP245225.RAlkuCuWMvpZb8WeK1Xwblyllg_IUxcYE3c7C8eoQQDbQ130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245225.RAlkuCuWMvpZb8WeK1Xwblyllg_IUxcYE3c7C8eoQQDbQ130_provenance.
- NP228159.RAHCN2ylHuugrYljnIneWI_NqwTYunCDPmbUemboz4PV0130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228159.RAHCN2ylHuugrYljnIneWI_NqwTYunCDPmbUemboz4PV0130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP97438.RAWQrMp0ODkgYx6ckszz1E4dQYb0GPqbhRjrxz18Ow8fQ130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97438.RAWQrMp0ODkgYx6ckszz1E4dQYb0GPqbhRjrxz18Ow8fQ130_provenance.